[使用胎儿医学基金会算法筛查和预防子痫前期]。

IF 0.6 4区 医学 Q4 OBSTETRICS & GYNECOLOGY Gynecologie Obstetrique Fertilite & Senologie Pub Date : 2024-10-03 DOI:10.1016/j.gofs.2024.09.007
Lola Loussert, Ninon Dupuis, Safouane M Hamdi, Paul Guerby, Christophe Vayssière
{"title":"[使用胎儿医学基金会算法筛查和预防子痫前期]。","authors":"Lola Loussert, Ninon Dupuis, Safouane M Hamdi, Paul Guerby, Christophe Vayssière","doi":"10.1016/j.gofs.2024.09.007","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>In order to identify women at high risk of pre-eclampsia and offer them aspirin prophylactic treatment, the Fetal Medicine Foundation (FMF) recommends a first-trimester screening test. The commonly used threshold for aspirin administration is a risk >1/100, which implies treating an important number of patients. We aimed to assess the use of this strategy with a more restrictive threshold: risk >1/70 and evaluate the impact of this strategy on the prevalence of pre-eclampsia with premature delivery in nulliparous women.</p><p><strong>Methods: </strong>A before-and-after cohort study conducted from 01/09/2014 to 01/12/2018, including nulliparous women undergoing first-trimester ultrasound at the University Hospital of Toulouse. Between 09/2014 and 09/2016 (\"before cohort\"), women did not undergo pre-eclampsia screening. Between 01/2017 and 12/2018 (\"after cohort\"), women underwent targeted pre-eclampsia screening using the FMF algorithm, and those with a risk >1/70 received 100mg aspirin. The primary outcome was pre-eclampsia with premature delivery. A univariate and then a multivariate analysis were performed to take into account potential confounding factors.</p><p><strong>Results: </strong>Among the 1030 women of the before cohort, 17 women (1.7%) experienced pre-eclampsia with premature delivery, compared to 8 women (1.3%) among the 629 of the after cohort, with no significant difference between the two groups (Adjusted Odd Ratio (95%CI)=0.73 [0.31-1.74]). In the after cohort, 18 women (2.9%) had a risk greater than 1/70 and therefore received aspirin. According to the FMF screening test, 89 women (14.1%) had a risk>1/100, which is the usual threshold for prescribing aspirin for prophylaxis. This means that 71 women had a risk greater than 1/100 but less than 1/70 and therefore did not receive aspirin in this study, even though they would have received aspirin at the usual threshold.</p><p><strong>Conclusions: </strong>The screening and prevention strategy for pre-eclampsia using restrictive thresholds did not decrease the rate of preeclampsia with premature delivery.</p>","PeriodicalId":56056,"journal":{"name":"Gynecologie Obstetrique Fertilite & Senologie","volume":" ","pages":""},"PeriodicalIF":0.6000,"publicationDate":"2024-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Screening and prevention of preeclampsia using the Fetal Medicine Foundation algorithm].\",\"authors\":\"Lola Loussert, Ninon Dupuis, Safouane M Hamdi, Paul Guerby, Christophe Vayssière\",\"doi\":\"10.1016/j.gofs.2024.09.007\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>In order to identify women at high risk of pre-eclampsia and offer them aspirin prophylactic treatment, the Fetal Medicine Foundation (FMF) recommends a first-trimester screening test. The commonly used threshold for aspirin administration is a risk >1/100, which implies treating an important number of patients. We aimed to assess the use of this strategy with a more restrictive threshold: risk >1/70 and evaluate the impact of this strategy on the prevalence of pre-eclampsia with premature delivery in nulliparous women.</p><p><strong>Methods: </strong>A before-and-after cohort study conducted from 01/09/2014 to 01/12/2018, including nulliparous women undergoing first-trimester ultrasound at the University Hospital of Toulouse. Between 09/2014 and 09/2016 (\\\"before cohort\\\"), women did not undergo pre-eclampsia screening. Between 01/2017 and 12/2018 (\\\"after cohort\\\"), women underwent targeted pre-eclampsia screening using the FMF algorithm, and those with a risk >1/70 received 100mg aspirin. The primary outcome was pre-eclampsia with premature delivery. A univariate and then a multivariate analysis were performed to take into account potential confounding factors.</p><p><strong>Results: </strong>Among the 1030 women of the before cohort, 17 women (1.7%) experienced pre-eclampsia with premature delivery, compared to 8 women (1.3%) among the 629 of the after cohort, with no significant difference between the two groups (Adjusted Odd Ratio (95%CI)=0.73 [0.31-1.74]). In the after cohort, 18 women (2.9%) had a risk greater than 1/70 and therefore received aspirin. According to the FMF screening test, 89 women (14.1%) had a risk>1/100, which is the usual threshold for prescribing aspirin for prophylaxis. This means that 71 women had a risk greater than 1/100 but less than 1/70 and therefore did not receive aspirin in this study, even though they would have received aspirin at the usual threshold.</p><p><strong>Conclusions: </strong>The screening and prevention strategy for pre-eclampsia using restrictive thresholds did not decrease the rate of preeclampsia with premature delivery.</p>\",\"PeriodicalId\":56056,\"journal\":{\"name\":\"Gynecologie Obstetrique Fertilite & Senologie\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.6000,\"publicationDate\":\"2024-10-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Gynecologie Obstetrique Fertilite & Senologie\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.gofs.2024.09.007\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"OBSTETRICS & GYNECOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Gynecologie Obstetrique Fertilite & Senologie","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.gofs.2024.09.007","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

目的:胎儿医学基金会(Fetal Medicine Foundation,FMF)建议,为了识别先兆子痫的高危产妇并为她们提供阿司匹林预防性治疗,应进行产前筛查。常用的阿司匹林用药阈值是风险>1/100,这意味着要治疗大量患者。我们的目的是评估这一策略在更严格的阈值(风险>1/70)下的使用情况,并评估这一策略对无先兆子痫妇女中先兆子痫合并早产患病率的影响:方法:2014年9月1日至2018年12月1日期间进行的前后队列研究,包括在图卢兹大学医院接受第一胎超声检查的无先兆子痫妇女。2014年9月9日至2016年9月9日期间("前队列"),妇女未接受子痫前期筛查。在2017年1月至2018年12月期间("后队列"),妇女使用FMF算法接受了有针对性的子痫前期筛查,风险>1/70的妇女接受了100毫克阿司匹林治疗。主要结果是先兆子痫合并早产。考虑到潜在的混杂因素,研究人员先进行了单变量分析,然后进行了多变量分析:在治疗前队列的 1030 名妇女中,有 17 名妇女(1.7%)出现先兆子痫并早产,而在治疗后队列的 629 名妇女中,有 8 名妇女(1.3%)出现先兆子痫并早产,两组间无显著差异(调整后奇数比 (95%CI) = 0.73 [0.31-1.74])。在后队列中,有 18 名妇女(2.9%)的风险大于 1/70,因此接受了阿司匹林治疗。根据 FMF 筛查测试,89 名妇女(14.1%)的风险大于 1/100,这是通常开具阿司匹林预防处方的阈值。这意味着有 71 名妇女的风险大于 1/100,但小于 1/70,因此在本研究中没有接受阿司匹林治疗,尽管按照通常的阈值,她们本应接受阿司匹林治疗:结论:采用限制性阈值的子痫前期筛查和预防策略并未降低子痫前期合并早产的发生率。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
[Screening and prevention of preeclampsia using the Fetal Medicine Foundation algorithm].

Objective: In order to identify women at high risk of pre-eclampsia and offer them aspirin prophylactic treatment, the Fetal Medicine Foundation (FMF) recommends a first-trimester screening test. The commonly used threshold for aspirin administration is a risk >1/100, which implies treating an important number of patients. We aimed to assess the use of this strategy with a more restrictive threshold: risk >1/70 and evaluate the impact of this strategy on the prevalence of pre-eclampsia with premature delivery in nulliparous women.

Methods: A before-and-after cohort study conducted from 01/09/2014 to 01/12/2018, including nulliparous women undergoing first-trimester ultrasound at the University Hospital of Toulouse. Between 09/2014 and 09/2016 ("before cohort"), women did not undergo pre-eclampsia screening. Between 01/2017 and 12/2018 ("after cohort"), women underwent targeted pre-eclampsia screening using the FMF algorithm, and those with a risk >1/70 received 100mg aspirin. The primary outcome was pre-eclampsia with premature delivery. A univariate and then a multivariate analysis were performed to take into account potential confounding factors.

Results: Among the 1030 women of the before cohort, 17 women (1.7%) experienced pre-eclampsia with premature delivery, compared to 8 women (1.3%) among the 629 of the after cohort, with no significant difference between the two groups (Adjusted Odd Ratio (95%CI)=0.73 [0.31-1.74]). In the after cohort, 18 women (2.9%) had a risk greater than 1/70 and therefore received aspirin. According to the FMF screening test, 89 women (14.1%) had a risk>1/100, which is the usual threshold for prescribing aspirin for prophylaxis. This means that 71 women had a risk greater than 1/100 but less than 1/70 and therefore did not receive aspirin in this study, even though they would have received aspirin at the usual threshold.

Conclusions: The screening and prevention strategy for pre-eclampsia using restrictive thresholds did not decrease the rate of preeclampsia with premature delivery.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Gynecologie Obstetrique Fertilite & Senologie
Gynecologie Obstetrique Fertilite & Senologie Medicine-Obstetrics and Gynecology
CiteScore
1.70
自引率
0.00%
发文量
170
期刊介绍: Gynécologie Obstétrique Fertilité & Sénologie est un mensuel scientifique d''information et de formation destiné aux gynécologues, aux obstétriciens, aux sénologues et aux biologistes de la reproduction. La revue, dans ses éditoriaux, articles originaux, mises au point, lettres à la rédaction et autres rubriques, donne une information actualisée ayant trait à l''obstétrique et à la gynécologie et aux différentes spécialités développées à partir de ces deux pôles : médecine de la reproduction, médecine maternelle et fœtale, périnatalité, endocrinologie, chirurgie gynécologique, cancérologie pelvienne, sénologie, sexualité, psychosomatique…
期刊最新文献
[Sexuality of the couple during pregnancy after assisted reproductive technology: a comparative study.] [The role of mammography in prevention of cardiovascular risk in women]. [Factors influencing pain during intrauterine device insertion]. [Reception of oocytes from partner (ROPA) in France: context and perspectives]. [Recommendations for clinical practice: Prevention and management of varicella zoster virus (VZV) infection during pregnancy and the perinatal period (extended version)].
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1